The neoplasm and inflammatory bowel disease in the patients with the preliminary diagnosis of irritable bowel syndrome

Journal Title: Gastroenterologia Polska - Year 2008, Vol 15, Issue 4

Abstract

Introduction: The family doctors often refer patients to the gastroenterology departments with a preliminary diagnosis of irritable bowel syndrome (IBS). However, some of the patients report also "alarm symptoms", which suggest a presence of the organic disease. Diagnostic procedures can lead to the change of the preliminary diagnosis in some cases. Aim of study: Our study was designed to evaluate the frequency of a neoplasm and inflammatory bowel disease (IBD) in patients with the preliminary diagnosis of IBS. Material and methods: Medical recordsof the 581 consecutive patients admitted inyears 2001-2008 to the Department of Gastroenterology and Hepatology of Wrocław Medical University with the preliminary diagnosis of IBS were reviewed.The group of the patients with the final diagnosis of neoplasm or IBD was selected. In the study group: age, gender, symptoms, the Rome III diagnostic criteria for the functional bowel disorders and diagnostic procedures were evaluated. Results:The neoplasm or IBD were finally diagnosed in 60 (10.3%) of the patients with the preliminary diagnosis of IBS. Among these patients 58.3% individuals met the Rome III diagnostic criteria for IBS. Conclusions: The knowledge of the Rome III criteria for IBS among family doctors is at insufficient level as we demonstrated lowagre-ement between the preliminary diagnosis of IBS and the diagnostic criteria. Moreover, patients who meet Rome III criteria and report alarm symptoms always require careful diagnostic to exclude the neoplasm or IBD. 

Authors and Affiliations

Agnieszka Lewandowska, Katarzyna Neubauer, Leszek Paradowski

Keywords

Related Articles

Complications of endoscopic therapy of pancreatic organized necrosis

Introduction: Pancreatic fluid collection (PFC) may be a complication of acute bout of pancreatitis. Their common feature is the presence of encystic pancreatic juice with or without necrotic debris. Acute and chronic ps...

The risk of malignancy in patients with celiac disease

Celiac disease (CD) is a lifelong disorder characterized by gluten intolerance. Forover 40 years CD was regarded as a disease strongly correlated with an increased risk of various malignancies, especially intestinal canc...

What is new in anus and anal canal diseases

In recentyears there has been a significant progress in the diagnostics and therapyof diseases of anus and anal canal.The progress in diagnostics includes both advancement in imaging diagnostics, such as 2D and 3D ultras...

Leczenie łagodnych zwężeń jelit po zespoleniach staplerowych za pomocą rozszerzaczy Hegara

Wprowadzenie: Zwężenia zespoleń kolorektalnych po zastosowaniu szwu mechanicznego według przytaczanych danych mogą występować aż u 30% chorych. Większość spośród tych zwężeń ma charakter łagodny, a średnica jelita w miej...

Tumor M2 pyruvate kinase – a tumor marker and indicator of inflammatory bowel disease activity 

Tumor M2-PK, the dimeric form of the isoenzyme PKM2 of pyruvate kinase, is secreted by all intensively proliferating cells, especially tumor cells. M2-PK can also be measured in plasma and stool. This marker seems to be...

Download PDF file
  • EP ID EP84189
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

Agnieszka Lewandowska, Katarzyna Neubauer, Leszek Paradowski (2008). The neoplasm and inflammatory bowel disease in the patients with the preliminary diagnosis of irritable bowel syndrome. Gastroenterologia Polska, 15(4), 237-240. https://europub.co.uk/articles/-A-84189